Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Recent advances in hair loss treatments show significant progress.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Substance from human umbilical cord blood cells promotes hair growth.

Non-immune factors play a significant role in alopecia areata.

New treatments for hair loss may target specific pathways and generate new hair follicles.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

A patient with complete hair loss regrew all her hair using tofacitinib.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Mitochondrial genes help predict breast cancer outcomes and spread.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.